As US President Barack Obama submitted his budget proposals on Monday, the Food and Drug Administration is requesting a budget of $4.3 billion to protect and promote the public health as part of the President's fiscal year 2012 budget - a 33% increase over the FDA enacted budget for FY 2010. The FY 2012 request covers the period of October 1, 2011, through September 30, 2012.
"FDA protects and promotes the health of all Americans through every stage of life," said FDA Commissioner Margaret Hamburg, adding: "The breadth of this mandate means that FDA responsibilities continue to grow. The new budget contains new resources so that FDA can fulfill its growing responsibilities to the American public."
The President’s proposals contain a number of provisions relating to generic patent settlements and the exclusivity of biologic drug copies, or biosimilars, which have angered the pharmaceutical industry (The Pharma Letter February 15).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze